T. Rowe Price Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-92,248
| Closed | -$43K | – | 3109 |
|
|
2025
Q1 | $43K | Buy |
92,248
+14,746
| +19% | +$9.3K | ﹤0.01% | 2945 |
|
|
2024
Q4 | $57K | Sell |
77,502
-39,677
| -34% | -$47.8K | ﹤0.01% | 2918 |
|
|
2024
Q3 | $184K | Hold |
117,179
| – | – | ﹤0.01% | 2680 |
|
|
2024
Q2 | $197K | Buy |
117,179
+11,864
| +11% | +$21.3K | ﹤0.01% | 2595 |
|
|
2024
Q1 | $253K | Buy |
105,315
+4,624
| +5% | +$9.93K | ﹤0.01% | 2513 |
|
|
2023
Q4 | $155K | Hold |
100,691
| – | – | ﹤0.01% | 2616 |
|
|
2023
Q3 | $110K | Sell |
100,691
-7,695
| -7% | -$13.5K | ﹤0.01% | 2646 |
|
|
2023
Q2 | $249K | Sell |
108,386
-48,235
| -31% | -$128K | ﹤0.01% | 2447 |
|
|
2023
Q1 | $381K | Sell |
156,621
-37,492
| -19% | -$85.9K | ﹤0.01% | 2230 |
|
|
2022
Q4 | $371K | Buy |
194,113
+838
| +0.4% | +$1.78K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $464K | Sell |
193,275
-4,166
| -2% | -$11.5K | ﹤0.01% | 2160 |
|
|
2022
Q2 | $367K | Buy |
197,441
+43,509
| +28% | +$83K | ﹤0.01% | 2354 |
|
|
2022
Q1 | $322K | Buy |
153,932
+10,300
| +7% | +$28.6K | ﹤0.01% | 2524 |
|
|
2021
Q4 | $566K | Buy |
143,632
+14,064
| +11% | +$68.3K | ﹤0.01% | 2329 |
|
|
2021
Q3 | $623K | Hold |
129,568
| – | – | ﹤0.01% | 2271 |
|
|
2021
Q2 | $595K | Buy |
129,568
+26,637
| +26% | +$128K | ﹤0.01% | 2306 |
|
|
2021
Q1 | $604K | Sell |
102,931
-77,144
| -43% | -$534K | ﹤0.01% | 2284 |
|
|
2020
Q4 | $616K | Sell |
180,075
-157,300
| -47% | -$300K | ﹤0.01% | 2160 |
|
|
2020
Q3 | $486K | Hold |
337,375
| – | – | ﹤0.01% | 2102 |
|
|
2020
Q2 | $673K | Buy |
337,375
+108,900
| +48% | +$213K | ﹤0.01% | 1943 |
|
|
2020
Q1 | $446K | Buy |
228,475
+35,100
| +18% | +$104K | ﹤0.01% | 2039 |
|
|
2019
Q4 | $803K | Buy |
193,375
+131,545
| +213% | +$506K | ﹤0.01% | 1978 |
|
|
2019
Q3 | $186K | Buy |
61,830
+188
| +0.3% | +$582 | ﹤0.01% | 2395 |
|
|
2019
Q2 | $388K | Buy |
61,642
+26,900
| +77% | +$161K | ﹤0.01% | 2216 |
|
|
2019
Q1 | $193K | Buy |
34,742
+800
| +2% | +$4.86K | ﹤0.01% | 2409 |
|
|
2018
Q4 | $225K | Buy |
33,942
+476
| +1% | +$3.86K | ﹤0.01% | 2378 |
|
|
2018
Q3 | $357K | Sell |
33,466
-141
| -0.4% | -$1.62K | ﹤0.01% | 2283 |
|
|
2018
Q2 | $403K | Buy |
33,607
+147
| +0.4% | +$1.5K | ﹤0.01% | 2240 |
|
|
2018
Q1 | $287K | Buy |
33,460
+284
| +0.9% | +$2.63K | ﹤0.01% | 2311 |
|
|
2017
Q4 | $328K | Sell |
33,176
-20,560
| -38% | -$214K | ﹤0.01% | 2250 |
|
|
2017
Q3 | $660K | Buy |
53,736
+20,600
| +62% | +$304K | ﹤0.01% | 1977 |
|
|
2017
Q2 | $545K | Hold |
33,136
| – | – | ﹤0.01% | 2032 |
|
|
2017
Q1 | $475K | Buy |
33,136
+17
| +0.1% | +$252 | ﹤0.01% | 2083 |
|
|
2016
Q4 | $458K | Hold |
33,119
| – | – | ﹤0.01% | 2084 |
|
|
2016
Q3 | $598K | Sell |
33,119
-17,600
| -35% | -$283K | ﹤0.01% | 1939 |
|
|
2016
Q2 | $728K | Buy |
50,719
+1,620
| +3% | +$22K | ﹤0.01% | 1815 |
|
|
2016
Q1 | $587K | Buy |
49,099
+25,100
| +105% | +$263K | ﹤0.01% | 1902 |
|
|
2015
Q4 | $319K | Sell |
23,999
-5,700
| -19% | -$70.1K | ﹤0.01% | 2131 |
|
|
2015
Q3 | $319K | Buy |
29,699
+5,900
| +25% | +$64.4K | ﹤0.01% | 2122 |
|
|
2015
Q2 | $192K | Buy |
23,799
+11,542
| +94% | +$84.8K | ﹤0.01% | 2359 |
|
|
2015
Q1 | $81K | Sell |
12,257
-855,399
| -99% | -$5.84M | ﹤0.01% | 2487 |
|
|
2014
Q4 | $5.53M | Sell |
867,656
-10,428
| -1% | -$84.1K | ﹤0.01% | 1444 |
|
|
2014
Q3 | $8.67M | Buy |
878,084
+3,214
| +0.4% | +$34.3K | ﹤0.01% | 1340 |
|
|
2014
Q2 | $9.86M | Sell |
874,870
-47,229
| -5% | -$507K | ﹤0.01% | 1322 |
|
|
2014
Q1 | $11.2M | Sell |
922,099
-3,942
| -0.4% | -$50.4K | ﹤0.01% | 1272 |
|
|
2013
Q4 | $11.7M | Sell |
926,041
-1,049,966
| -53% | -$16.7M | ﹤0.01% | 1247 |
|
|
2013
Q3 | $32.8M | Sell |
1,976,007
-84,040
| -4% | -$1.41M | 0.01% | 954 |
|
|
2013
Q2 | $31.3M | Buy |
+2,060,047
| New | +$31.3M | 0.01% | 941 |
|
Other funds holding LXRX
AG
SL
SSA
SC
GCP
